We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 678.00
Bid: 0.00
Ask: 740.00
Change: 0.00 (0.00%)
Spread: 64.00 (9.467%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 678.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European Expansion in Hot Isostatic Pressing

24 Jan 2018 07:00

RNS Number : 7205C
Bodycote PLC
24 January 2018
 

24 January 2018

 

BODYCOTE CONFIRMS EUROPEAN EXPANSION IN HOT ISOSTATIC PRESSING

NEW MEGA-HIP VESSEL SCHEDULED FOR 2018 DELIVERY

MACCLESFIELD (U.K.) - Bodycote, the world's largest provider of heat treatment and specialist thermal processing services, is pleased to announce that its Sint Niklaas, Belgium, Hot Isostatic Pressing (HIP) location will take delivery of a new "Mega-HIP" unit which will be operational by the end of 2018.

The new high pressure, high temperature Mega-HIP is Nadcap capable to meet the growing demand of the European aerospace market over the next five years and beyond. This investment will significantly increase Bodycote's Nadcap HIP capacity globally, in addition to the substantial increase in Nadcap capacity which Bodycote completed in 2017. These recent investments highlight Bodycote's commitment to expand its global HIP capacity to meet market requirements.

In addition to aerospace, Bodycote HIP serves clients around the world in markets as diverse as medical, power generation, marine, nuclear, automotive and electronics with both HIP services and its Powdermet® technologies. The recently launched Powdermet® technologies incorporate new, patent-pending techniques that combine 3D printing with well-established net shape and near net shape (NNS) techniques. This new hybrid technology dramatically reduces the manufacturing time and production cost of a part compared to producing the same part using 3D printing alone.

Bodycote operates the world's largest HIP equipment network and continues to invest in recognition of growing demand for HIP technology. Having established HIP expertise over several decades, Bodycote has over 50 HIP vessels of varying sizes in multiple locations. Processing capability can accommodate components which are nominally up to 2m diameter by 3.5 m high; and weighing 0.1kg to over 30,000kg. In addition to standard quality and environmental accreditations, Bodycote's HIP facilities also hold ASTM and NORSOK accreditations.

- Ends -

 

 

About Bodycote

With more than 180 accredited facilities in 23 countries, Bodycote is the world's largest provider of heat treating and specialist thermal processing services. Through classical heat treatment and specialist technologies including Hot Isostatic Pressing (HIP), Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, oil & gas, construction, medical and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 30 years. For more information, visit www.bodycote.com.

 

For more information, please contact:

Jim Sheard, Senior Vice President, Sales, Hot Isostatic Pressing

Email: jim.sheard@bodycote.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABIGDBBBDBGIX
Date   Source Headline
22nd Apr 20247:00 amPRNTransaction in Own Shares
19th Apr 20247:00 amPRNTransaction in Own Shares
18th Apr 20247:00 amPRNTransaction in Own Shares
17th Apr 20247:00 amPRNTransaction in Own Shares
16th Apr 20247:00 amPRNTransaction in Own Shares
15th Apr 20247:00 amPRNTransaction in Own Shares
12th Apr 20247:00 amPRNTransaction in Own Shares
11th Apr 20247:00 amPRNTransaction in Own Shares
10th Apr 20247:00 amPRNTransaction in Own Shares
9th Apr 20247:00 amPRNTransaction in Own Shares
8th Apr 20247:00 amPRNTransaction in Own Shares
5th Apr 20247:00 amPRNTransaction in Own Shares
4th Apr 20249:50 amPRNAnnual Financial Report
4th Apr 20247:00 amPRNTransaction in Own Shares
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20249:47 amPRNHolding(s) in Company
2nd Apr 20249:41 amPRNHolding(s) in Company
2nd Apr 20248:35 amPRNTransaction in Own Shares
28th Mar 20247:00 amPRNTransaction in Own Shares
27th Mar 20247:00 amPRNTransaction in Own Shares
26th Mar 20247:00 amPRNTransaction in Own Shares
25th Mar 20243:07 pmPRNDirector/PDMR Shareholding
25th Mar 20247:00 amPRNTransaction in Own Shares
22nd Mar 20247:00 amPRNTransaction in Own Shares
21st Mar 20242:55 pmPRNDirector/PDMR Shareholding
21st Mar 20242:29 pmPRNDirector/PDMR Shareholding
21st Mar 20247:00 amPRNTransaction in Own Shares
20th Mar 20247:00 amPRNTransaction in Own Shares
19th Mar 202411:24 amPRNDirector/PDMR Shareholding
19th Mar 20247:00 amPRNTransaction in Own Shares
18th Mar 20247:00 amPRNTransaction in Own Shares
15th Mar 20247:10 amRNSLaunch of £60 million Share Buyback Programme
15th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
11th Mar 20247:00 amPRNBoard Change
1st Mar 20249:27 amPRNDirector Declaration
29th Feb 20244:30 pmPRNTotal Voting Rights
31st Jan 20244:30 pmPRNTotal Voting Rights
31st Jan 20243:57 pmPRNBodycote plc - Holding(s) in Company
22nd Jan 20247:00 amRNSAcquisition Update and Share Buyback Programme
8th Jan 20244:37 pmPRNHolding(s) in Company
29th Dec 202312:25 pmPRNTotal Voting Rights
8th Dec 20234:40 pmPRNDirector/PDMR Shareholding
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.